Authors: Belfiglio, M De Berardis, G Franciosi, M Cavaliere, D Di Nardo, B Greenfield, S Kaplan, SH Pellegrini, F Sacco, M Tognoni, G Valentini, M Nicolucci, A Caimi, V Capani, F Corsi, A Della Vedova, R Benedetti, MM Nicolucci, A Taboga, C Tombesi, M Vespasiani, G

Citation: M. Belfiglio et al., The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes - The QuED Study Group - Quality of care and outcomes in type 2 diabetes, DIABET CARE, 24(3), 2001, pp. 423-429

Authors: Franciosi, M Pellegrini, F De Berardis, G Belfiglio, M Cavaliere, D Di Nardo, B Greenfield, S Kaplan, SH Sacco, M Tognoni, G Valentini, M Nicolucci, A

Citation: M. Franciosi et al., The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients - An urgent need for better educational strategies, DIABET CARE, 24(11), 2001, pp. 1870-1877

Authors: Mari, E Floriani, I Tinazzi, A Buda, A Belfiglio, M Valentini, M Cascinu, S Barni, S Labianca, R Torri, V

Citation: E. Mari et al., Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials - A study of the GISCAD(Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente), ANN ONCOL, 11(7), 2000, pp. 837-843

Authors: Belfiglio, M Cavaliere, D De Berardis, G Carinci, F Di Nardo, B Franciosi, M Pellegrini, F Tognoni, G Nicolucci, A

Citation: M. Belfiglio et al., Attitudes of Italian physicians towards intensive metabolic control in Type 2 diabetes, DIABET NUTR, 13(3), 2000, pp. 149-155

Authors: Valentini, M Mari, E Belfiglio, M Nicolucci, A

Citation: M. Valentini et al., Is adjuvant tamoxifen used optimally in the treatment of breast cancer? Results of an Italian survey, ANN ONCOL, 10(7), 1999, pp. 789-793

Authors: Scorpiglione, N Belfiglio, M Carinci, F Cavaliere, D De Curtis, A Franciosi, M Mari, E Sacco, M Tognoni, G Nicolucci, A

Citation: N. Scorpiglione et al., The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with type II diabetes mellitus - A model of medicine-based evidence, EUR J CL PH, 55(4), 1999, pp. 239-249